High Tolerability, Favorable Safety, and Subjects' Preference for a Single 200 mg/2 mL Tildrakizumab Injection: A Phase I, Open-Label, Randomized Crossover Trial in Healthy Volunte...

por Kokolakis, Georgios, Kreis, German, Falqués, Meritxell, Aparici, Mònica, Sondermann, Wiebke
Publicado 2022

Typical investigational medicinal products follow relatively uniform regulations in 10 European Clinical Research Infrastructures Network (ECRIN) countries

por Gluud, Christian, Kubiak, Christine, Whitfield, Kate, Byrne, Jane, Huemer, Karl-Heinz, Thirstrup, Steffen, Libersa, Christian, Barraud, Béatrice, Grählert, Xina, Dreier, Gabriele, Geismann, Sebastian, Kuchinke, Wolfgang, Temesvari, Zsuza, Blasko, Gyorgy, Kardos, Gabriella, O'Brien, Timothy, Cooney, Margaret, Gaynor, Siobhan, Schieppati, Arrigo, de Andres, Fernando, Sanz, Nuria, Kreis, German, Asker-Hagelberg, Charlotte, Johansson, Hanna, Bourne, Sue, Asghar, Adeeba, Husson, Jean-Marc, Demotes-Mainard, Jacques
Publicado 2012

Compassionate use of interventions: results of a European Clinical Research Infrastructures Network (ECRIN) survey of ten European countries

por Whitfield, Kate, Huemer, Karl-Heinz, Winter, Diana, Thirstrup, Steffen, Libersa, Christian, Barraud, Béatrice, Kubiak, Christine, Stankovski, Lea, Grählert, Xina, Dreier, Gabriele, Geismann, Sebastian, Kuchinke, Wolfgang, Strenge-Hesse, Anke, Temesvari, Zsuza, Blasko, Gyorgy, Kardos, Gabriella, O'Brien, Timothy, Cooney, Margaret, Gaynor, Siobhan, Schieppati, Arrigo, Serrano, Mariantonia, de Andres, Fernando, Sanz, Nuria, Hernández, Raquel, Kreis, Germán, Asker-Hagelberg, Charlotte, Johansson, Hanna, Asghar, Adeeba, Husson, Jean-Marc, Demotes, Jacques, Gluud, Christian
Publicado 2010